medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2019, Number 1

<< Back Next >>

Ann Hepatol 2019; 18 (1)

ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis

Oikonomou T, Goulis I, Doumtsis P, Tzoumari T, Akriviadis E, Cholongitas E

Language: English
References: 31
Page: 126-136
PDF size: 190.10 Kb.


ABSTRACT

Introduction and aim. Studies carried out mainly in patients with hepatocellular carcinoma (HCC), have shown the prognostic significance of albumin-bilirubin (ALBI) grade. Recently, another predictive score incorporating platelet count into ALBI, PALBI grade, was introduced in patients with HCC. Aim. We evaluated the ability of ALBI and PALBI grades in predicting the outcome (mortality / liver transplantation) of patients with stable decompensated cirrhosis with various etiology of liver diseases. Material and methods. We prospectively studied 325 patients with stable decompensated cirrhosis awaiting liver transplantation. Their clinical and laboratory characteristics were recorded including albumin, bilirubin levels, platelets. We estimated ALBI and PALBI grades for every patient. Conventional prognostic scores were also evaluated; Child-Pugh (CTP), Model for End stage Liver Disease (MELD). We followed them up and recorded their outcome. Results. Beyond MELD and CTP, ALBI and PALBI grades proved significant factors associated with the outcome (HR: 2.13, 95%CI [1.59, 2.85], p ‹ 0.001 and HR: 2.06, 95%CI [1.47, 2.9], p ‹ 0.001, respectively), and their predictive capability was established (ROC analysis; AUC: 0.695, 95% CI [0.634, 0.755] and AUC: 0.683, 95% CI [0.621, 0.744], respectively). ALBI and PALBI performed better than CTP score (p = 0.0044 and p = 0.014, respectively). Categorization of our patients into three ALBI groups detected statistically different survival times. Accordingly, PALBI grade 3 compared to those with PALBI grade 1 and 2 patients, had worse outcome and significantly higher frequency of cirrhosis-related complications. Conclusions. ALBI and PALBI grades were validated and can be used to predict the outcome in patients with stable decompensated cirrhosis.


REFERENCES

  1. Schuppan D, Afdhal NH. Seminar Liver cirrhosis. Lancet 2008; 371: 838-51.

  2. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.

  3. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Chil Pugh versus MELD. J Hepatol 2005; 42: 100-7.

  4. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40: 897-903.

  5. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006; 12: 1049-61.

  6. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.

  7. Vitale A, Bertacco A, Gambato M, D’Amico F, Morales RR, Frigo AC, Zanus G, et al. Model for end-stage liver diseasesodium and survival benefit in liver transplantation. Transpl Int 2013; 26: 138-44.

  8. Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, O’Beirne J, et al. Assessment of liver function in patients with hepatocellular carcinoma: A new evidencebased approach - The ALBI grade. J Clin Oncol 2015; 33: 550-8.

  9. Roayaie PS, Jibara G, Berhane S, Tabrizian P, Park JW, Yang J, Yan L, et al. PALBI-An Objective Score Based on Platelets, Albumin & Bilirubin Stratifies HCC Patients Undergoing Resection & Ablation Better than Child’s Classification. In AASLD LiverLearning®; 2015.

  10. Chan AWH, Chan RCK, Wong GLH, Wong VWS, Choi PCL, Chan HLY, To KF. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score. J Gastroenterol Hepatol 2015; 30: 1391-6.

  11. Chen RC, Cai YJ, Wu JM, Wang XD, Song M, Wang YQ, Zheng MH, et al. Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis. J Viral Hepat 2017; 24: 238-45.

  12. Walker AJ, Johnson PJ, Berhane S. Liver function as measured by albumin-bilirubin score within decompensated patients receiving direct acting antiviral therapy. In: The International Liver Congress 2017. Amsterdam, The Netherlands 19-23 April; 2017.

  13. Elshaarawy O, Samea EA, Gomaa A, Allam N, Saad M. Palbi- The Platelet-Albumin-Bilirubin score- A better predictor of outcome of Acute Variceal Bleeding. In: The International Liver Congress 2017. Amsterdam, The Netherlands 19-23 April; 2017.

  14. Udell JA, Wang CS, Tinmouth J, FitzGerald JM, Najib TA, Simel DL, Schulzer M, et al. Does This Patient With Liver Disease Have Cirrhosis? JAMA 2012; 307: 832-42.

  15. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection Of The Oesophagus For Bleeding Oesophageal Varices. Brit J Surg 1973; 60: 1971-4.

  16. Soulaidopoulos S, Goulis I, Giannakoulas G, Panagiotidis T, Doumtsis P, Karasmani A, Oikonomou T, et al. Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis. Ann Gastroenterol 2017; 30: 225-31.

  17. Fleming JS, Nunan TO, Society BNM. The new BNMS guidelines for measurement of glomerular filtration rate. Nucl Med Commun 2004; 25: 755-7.

  18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.

  19. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.

  20. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet 2014; 383: 1749-61.

  21. Peng Y, Qi X, Guo X. Child–Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis. Medicine (Baltimore) 2016; 95: 1-29.

  22. Chan AWH, Kumada T, Toyoda H, Tada T, Chong CCN, Mo FKF, Yeo W, et al. Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma. J Gastroenterol Hepatol 2016; 31: 1300-6.

  23. Chan AWH, Chong CCN, Mo FKF, Wong J, Yeo W, Johnson PJ, Yu S, et al. Incorporating Albumin-Bilirubin grade into the Cancer of the Liver Italian Program system for hepatocellular carcinoma. J Gastroenterol Hepatol 2016; 32: 221-8.

  24. Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, et al. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2016; 31: 1031-6.

  25. Li MX, Zhao H, Bi XY, Li ZY, Huang Z, Han Y, Zhou JG, et al. Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma: Validation in a Chinese cohort. Hepatol Res 2017; 47: 731-41.

  26. Kuo YH, Wang JH, Hung CH, Rau KM, Wu IP, Chen CH, Knee KM, et al. The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib. J Gastroenterol Hepatol 2017; 11 [Epub ahead of print].

  27. Ogasawara S, Chiba T, Ooka Y, Suzuki E, Kanogawa N, Saito T, Motoyama T, et al. Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma. Invest New Drugs 2015; 33: 1257-62.

  28. Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, Xiang BD, Ma L, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg 2016; 103: 725-34.

  29. Ma XL, Zhou JY, Gao XH, Tian L, Wu J, Zhang CY, Zhou Y, et al. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with earlystage hepatocellular carcinoma. Clin Chim Acta 2016; 462: 15-22.

  30. Zou D, Qi X, Zhu C, Ning Z, Hou F, Zhao J, Peng Y, et al. Albumin- bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study. Turk J Gastroenterol 2016; 27: 180-6.

  31. Liu PH, Hsu CY, Hsia Y, Lee YH, Chiou YY, Huang YH, Lee FY, et al. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era. J Gastroenterol Hepatol 2017; 32: 879-86.




2020     |     www.medigraphic.com